Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis

Ping L. Zhang(Beaumont Hospital), Robert Brown(Emerson College)

Modern Pathology

May 27, 2005

10.1038/modpathol.3800372

Cited by 62

Related Papers

Tubular Expression of KIM-1 Does not Predict Delayed Function After Transplantation

|Journal of the American Society of Nephrology|2009|67

Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide

|Oncoscience|2016|36

A phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of the histone deacetylase (HDAC) inhibitor PXD101 in patients (pts) with advanced solid tumours

|Journal of Clinical Oncology|2005|19

Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: Pathogenesis and therapeutic options

|Oncotarget|2016|14

Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options

|Oncotarget|2016|10